This UK population study introduces lifetime risk of revision as a patient-facing metric for hip and knee replacement. Using registry implant-survival data adjusted for all-cause mortality, it asks how age at primary surgery changes the chance a patient will eventually need revision. The goal is better-informed counseling, especially for younger patients deciding when to operate.
When a 52-year-old man asks how long his new knee will last, the honest answer is not the reassuring 10-year survival quote. This paper reframes the question as lifetime risk, and for that patient the number approaches one in three. He should understand he may face a revision, often within 5 years, and then spend decades with a revision implant that performs worse.
The mirror image is the patient over 70, whose lifetime revision risk is about 5% because competing mortality intervenes before the implant fails. Longevity anxiety is misplaced here. The testable mental model: revision risk is driven by age and sex at implantation, not just implant design. Younger age and male sex both push risk up.
The study's strength is its population-level CPRD dataset validated against the NJR. Its limits are real too: no implant type, indication, or bearing-surface data, and all-cause mortality may overestimate risk in this relatively healthy surgical population.
This UK population study introduces lifetime risk of revision as a patient-facing metric for hip and knee replacement. Using registry implant-survival data adjusted for all-cause mortality, it asks how age at primary surgery changes the chance a patient will eventually need revision. The goal is better-informed counseling, especially for younger patients deciding when to operate.
When a 52-year-old man asks how long his new knee will last, the honest answer is not the reassuring 10-year survival quote. This paper reframes the question as lifetime risk, and for that patient the number approaches one in three. He should understand he may face a revision, often within 5 years, and then spend decades with a revision implant that performs worse.
The mirror image is the patient over 70, whose lifetime revision risk is about 5% because competing mortality intervenes before the implant fails. Longevity anxiety is misplaced here. The testable mental model: revision risk is driven by age and sex at implantation, not just implant design. Younger age and male sex both push risk up.
The study's strength is its population-level CPRD dataset validated against the NJR. Its limits are real too: no implant type, indication, or bearing-surface data, and all-cause mortality may overestimate risk in this relatively healthy surgical population.